Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Endothelial indoleamine 2,3-dioxygenase protects against development of pulmonary hypertension.

Xiao Y, Christou H, Liu L, Visner G, Mitsialis SA, Kourembanas S, Liu H.

Am J Respir Crit Care Med. 2013 Aug 15;188(4):482-91. doi: 10.1164/rccm.201304-0700OC.

2.

Soluble JAGGED1 inhibits pulmonary hypertension by attenuating notch signaling.

Xiao Y, Gong D, Wang W.

Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2733-9. doi: 10.1161/ATVBAHA.113.302062. Epub 2013 Sep 26.

3.

Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells.

Xia S, Tai X, Wang Y, An X, Qian G, Dong J, Wang X, Sha B, Wang D, Murthi P, Kalionis B, Wang X, Bai C.

Am J Respir Cell Mol Biol. 2011 Jan;44(1):66-73. doi: 10.1165/rcmb.2008-0442OC. Epub 2010 Feb 16.

PMID:
20160044
4.
5.

Myoendothelial gap junctional signaling induces differentiation of pulmonary arterial smooth muscle cells.

Gairhe S, Bauer NN, Gebb SA, McMurtry IF.

Am J Physiol Lung Cell Mol Physiol. 2011 Oct;301(4):L527-35. doi: 10.1152/ajplung.00091.2011. Epub 2011 Jul 29.

6.

Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling.

Tian X, Vroom C, Ghofrani HA, Weissmann N, Bieniek E, Grimminger F, Seeger W, Schermuly RT, Pullamsetti SS.

PLoS One. 2011 Apr 11;6(4):e18136. doi: 10.1371/journal.pone.0018136.

7.

Role of Src tyrosine kinases in experimental pulmonary hypertension.

Pullamsetti SS, Berghausen EM, Dabral S, Tretyn A, Butrous E, Savai R, Butrous G, Dahal BK, Brandes RP, Ghofrani HA, Weissmann N, Grimminger F, Seeger W, Rosenkranz S, Schermuly RT.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1354-65. doi: 10.1161/ATVBAHA.112.248500. Epub 2012 Apr 19.

8.

Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension.

Preston IR, Sagliani KD, Warburton RR, Hill NS, Fanburg BL, Jaffe IZ.

Am J Physiol Lung Cell Mol Physiol. 2013 May 15;304(10):L678-88. doi: 10.1152/ajplung.00300.2012. Epub 2013 Mar 1.

9.

PAR-2 inhibition reverses experimental pulmonary hypertension.

Kwapiszewska G, Markart P, Dahal BK, Kojonazarov B, Marsh LM, Schermuly RT, Taube C, Meinhardt A, Ghofrani HA, Steinhoff M, Seeger W, Preissner KT, Olschewski A, Weissmann N, Wygrecka M.

Circ Res. 2012 Apr 27;110(9):1179-91. doi: 10.1161/CIRCRESAHA.111.257568. Epub 2012 Mar 29.

10.

Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease model.

Pak O, Sommer N, Hoeres T, Bakr A, Waisbrod S, Sydykov A, Haag D, Esfandiary A, Kojonazarov B, Veit F, Fuchs B, Weisel FC, Hecker M, Schermuly RT, Grimminger F, Ghofrani HA, Seeger W, Weissmann N.

Am J Respir Cell Mol Biol. 2013 Sep;49(3):358-67. doi: 10.1165/rcmb.2012-0361OC.

PMID:
23590303
11.

Characterization of proximal pulmonary arterial cells from chronic thromboembolic pulmonary hypertension patients.

Quarck R, Wynants M, Ronisz A, Sepulveda MR, Wuytack F, Van Raemdonck D, Meyns B, Delcroix M.

Respir Res. 2012 Mar 27;13:27. doi: 10.1186/1465-9921-13-27.

12.

Glycogen synthase kinase 3beta contributes to proliferation of arterial smooth muscle cells in pulmonary hypertension.

Sklepkiewicz P, Schermuly RT, Tian X, Ghofrani HA, Weissmann N, Sedding D, Kashour T, Seeger W, Grimminger F, Pullamsetti SS.

PLoS One. 2011 Apr 18;6(4):e18883. doi: 10.1371/journal.pone.0018883.

13.

Notch signaling change in pulmonary vascular remodeling in rats with pulmonary hypertension and its implication for therapeutic intervention.

Qiao L, Xie L, Shi K, Zhou T, Hua Y, Liu H.

PLoS One. 2012;7(12):e51514. doi: 10.1371/journal.pone.0051514. Epub 2012 Dec 12.

14.

Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice.

Satoh K, Kagaya Y, Nakano M, Ito Y, Ohta J, Tada H, Karibe A, Minegishi N, Suzuki N, Yamamoto M, Ono M, Watanabe J, Shirato K, Ishii N, Sugamura K, Shimokawa H.

Circulation. 2006 Mar 21;113(11):1442-50. Epub 2006 Mar 13.

15.

Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.

Paffett ML, Lucas SN, Campen MJ.

Vascul Pharmacol. 2012 Jan-Feb;56(1-2):64-73. doi: 10.1016/j.vph.2011.11.002. Epub 2011 Nov 25.

16.

Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle-like cells regulated by myocardin involved in hypoxia-induced pulmonary vascular remodelling.

Zhu P, Huang L, Ge X, Yan F, Wu R, Ao Q.

Int J Exp Pathol. 2006 Dec;87(6):463-74. Erratum in: Int J Exp Pathol. 2007 Apr;88(2):127-8.

17.

The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation.

Green DE, Murphy TC, Kang BY, Kleinhenz JM, Szyndralewiez C, Page P, Sutliff RL, Hart CM.

Am J Respir Cell Mol Biol. 2012 Nov;47(5):718-26. doi: 10.1165/rcmb.2011-0418OC. Epub 2012 Aug 16.

18.

miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling.

Yang S, Banerjee S, Freitas Ad, Cui H, Xie N, Abraham E, Liu G.

Am J Physiol Lung Cell Mol Physiol. 2012 Mar 15;302(6):L521-9. doi: 10.1152/ajplung.00316.2011. Epub 2012 Jan 6.

19.

Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension.

Li XH, Peng J, Tan N, Wu WH, Li TT, Shi RZ, Li YJ.

Vascul Pharmacol. 2010 Nov-Dec;53(5-6):223-9. doi: 10.1016/j.vph.2010.09.002. Epub 2010 Sep 16.

PMID:
20840872
20.

Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.

Yang J, Li X, Al-Lamki RS, Wu C, Weiss A, Berk J, Schermuly RT, Morrell NW.

Arterioscler Thromb Vasc Biol. 2013 Jan;33(1):34-42. doi: 10.1161/ATVBAHA.112.300121. Epub 2012 Nov 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk